• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COL1A1:PDGFB嵌合转录本不存在于皮肤的未定型纤维组织细胞性病变中。

COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.

作者信息

Wang Wei-Lien, Patel Kayuri U, Coleman Neil M, Smith-Zagone Megan J, Ivan Doina, Reed Jon A, López-Terrada Dolores, Lazar Alexander J F, Prieto Victor G

机构信息

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.

出版信息

Am J Dermatopathol. 2010 Apr;32(2):149-53. doi: 10.1097/DAD.0b013e3181b0b876.

DOI:10.1097/DAD.0b013e3181b0b876
PMID:19940748
Abstract

Indeterminate fibrohistiocytic lesions of the skin share histological and immunohistochemical features of both benign fibrous histiocytoma/dermatofibroma and dermatofibrosarcoma protuberans (DFSP). Unlike dermatofibroma, DFSP harbors recurrent genetic aberrations resulting in the fusion of COL1A1 on chromosome 17 and PDGFB on chromosome 22. Because indeterminate fibrohistiocytic lesions share some features with DFSP, they were evaluated for the possible presence of COL1A1-PDGFB chimeric transcripts. Twelve formalin-fixed paraffin-embedded cases were examined for COL1A1-PDGFB chimeric transcripts using a previously validated sensitive multiplex reverse transcriptase-polymerase chain reaction assay. The median patient age was 52.5 years (33-70 years) with 9 females and 3 males. The most common site was the extremities (n = 8) followed by the trunk (n = 2) and the head and neck region (n = 2). All demonstrated the expected reactivity for both CD34 and factor XIIIa, and the majority focally infiltrated into subcutaneous fat. Of the 6 patients with follow-up, 2 had residual tumor excised, but no patient developed a recurrence. None of the tumors harbored COL1A1-PDGFB fusion transcripts identified by reverse transcriptase-polymerase chain reaction. Although indeterminate fibrohistiocytic lesions share some features with DFSP, the lack of COL1A1-PDGFB chimeric transcripts suggests that they are distinct entities.

摘要

皮肤的不典型纤维组织细胞性病变具有良性纤维组织细胞瘤/皮肤纤维瘤和隆突性皮肤纤维肉瘤(DFSP)的组织学及免疫组化特征。与皮肤纤维瘤不同,DFSP存在复发性基因畸变,导致17号染色体上的COL1A1与22号染色体上的PDGFB融合。由于不典型纤维组织细胞性病变与DFSP有一些共同特征,因此对其进行了COL1A1 - PDGFB嵌合转录本的检测。使用先前验证的灵敏多重逆转录酶 - 聚合酶链反应分析法,对12例福尔马林固定石蜡包埋病例检测COL1A1 - PDGFB嵌合转录本。患者中位年龄为52.5岁(33 - 70岁),女性9例,男性3例。最常见部位为四肢(n = 8),其次为躯干(n = 2)和头颈部(n = 2)。所有病例CD34和因子ⅩⅢa均呈预期反应,多数病例局灶性浸润至皮下脂肪。6例有随访的患者中,2例切除了残留肿瘤,但无患者复发。逆转录酶 - 聚合酶链反应未检测到任何肿瘤存在COL1A1 - PDGFB融合转录本。尽管不典型纤维组织细胞性病变与DFSP有一些共同特征,但缺乏COL1A1 - PDGFB嵌合转录本提示它们是不同的实体。

相似文献

1
COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.COL1A1:PDGFB嵌合转录本不存在于皮肤的未定型纤维组织细胞性病变中。
Am J Dermatopathol. 2010 Apr;32(2):149-53. doi: 10.1097/DAD.0b013e3181b0b876.
2
Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.当通过新开发的多重逆转录聚合酶链反应和荧光原位杂交检测法进行研究时,几乎在所有隆突性皮肤纤维肉瘤病例中都能鉴定出隆突性皮肤纤维肉瘤COL1A1-PDGFB融合基因。
Hum Pathol. 2008 Feb;39(2):184-93. doi: 10.1016/j.humpath.2007.06.009. Epub 2007 Oct 24.
3
Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.斑块样 CD34 阳性真皮纤维瘤(“勋章样真皮树突状细胞瘤样错构瘤”):5 例临床病理、免疫组化和分子分析,强调其与浅表性、斑块样隆突性皮肤纤维肉瘤的区别。
Am J Surg Pathol. 2010 Feb;34(2):190-201. doi: 10.1097/PAS.0b013e3181c7cf11.
4
A novel fusion gene of collagen type I alpha 1 (exon 31) and platelet-derived growth factor B-chain (exon 2) in dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤中一种新的I型胶原蛋白α1(第31外显子)与血小板衍生生长因子B链(第2外显子)的融合基因。
Eur J Dermatol. 2007 May-Jun;17(3):217-9. doi: 10.1684/ejd.2007.0151. Epub 2007 May 4.
5
Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.隆突性皮肤纤维肉瘤:临床、病理及遗传学(COL1A1-PDGFB)研究及其治疗意义
Histopathology. 2009 Jun;54(7):860-72. doi: 10.1111/j.1365-2559.2009.03310.x.
6
Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays.应用荧光原位杂交技术在石蜡包埋组织微阵列中鉴定隆突性皮肤纤维肉瘤中的 t(17;22)(q22;q13) (COL1A1/PDGFB)
Hum Pathol. 2011 Feb;42(2):176-84. doi: 10.1016/j.humpath.2010.07.015. Epub 2010 Dec 15.
7
Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.黏液样隆突性皮肤纤维肉瘤:8例临床病理、免疫组化及分子分析
Am J Dermatopathol. 2007 Oct;29(5):443-8. doi: 10.1097/DAD.0b013e318145413c.
8
Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans.成人浅表性纤维肉瘤中COL1A1-PDGFB融合转录本的表达表明其与隆突性皮肤纤维肉瘤关系密切。
J Pathol. 2001 May;194(1):88-94. doi: 10.1002/path.839.
9
PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.在隆突性皮肤纤维肉瘤中 PDGFB 重排:与临床病理特征的相关性及其临床意义。
Hum Pathol. 2013 Jul;44(7):1300-9. doi: 10.1016/j.humpath.2012.09.021. Epub 2013 Jan 22.
10
Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.转化型隆突性皮肤纤维肉瘤:肉瘤区域中COL1A1-PDGFB融合转录本的实时聚合酶链反应检测
J Clin Pathol. 2007 Feb;60(2):190-4. doi: 10.1136/jcp.2006.037200. Epub 2006 May 26.

引用本文的文献

1
Dermatofibromas with Aberrant Expression of CD34 Protein: A Systematic Review and a Reappraisal of Clinicopathological Features and Histogenesis.伴有CD34蛋白异常表达的皮肤纤维瘤:一项系统评价及对临床病理特征和组织发生的重新评估
Diagnostics (Basel). 2023 Jan 4;13(2):185. doi: 10.3390/diagnostics13020185.